Herlev Hospital is a hospital in Herlev, Denmark, close to Copenhagen. The building is 120 metres tall and has 25 floors. It is famous for being Denmark's tallest building. Its modern, functional architecture in bright concrete, glass and bronze-colored aluminum gives a unique impression.

During the past decade, Herlev hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 4 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herlev hospital" #1 sponsor was "Herlev Hospital" with 10 trials, followed by "Copenhagen University Hospital at Herlev" with 6 trials sponsored, "Rigshospitalet, Denmark" with 6 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "Copenhagen University Hospital, Hvidovre" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herlev hospital" #1 collaborator was "Herlev Hospital" with 11 trials as a collaborator, "University of Copenhagen" with 9 trials as a collaborator, "Zealand University Hospital" with 7 trials as a collaborator, "Odense University Hospital" with 6 trials as a collaborator and "Rigshospitalet, Denmark" with 6 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Herlev hospital" are "Anxiety" (3 trials), "Anemia, Hemolytic" (2 trials), "Breast Cancer" (2 trials), "COPD" (2 trials) and "Closed-Loop Communication" (2 trials). Many other conditions were trialed in "Herlev hospital" in a lesser frequency.

Most popular intervention types in "Herlev hospital" are "Drug" (21 trials), "Other" (9 trials), "Procedure" (8 trials), "Device" (7 trials) and "Dietary Supplement" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "AG-348" (2 trials), "Docetaxel" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Herlev hospital" are 52 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Herlev hospital". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Herlev hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Herlev hospital, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".